The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

about

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

Item

http://www.wikidata.org/entity/Q47291065

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@en

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@nl

type

Item

label

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@en

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@nl

prefLabel

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@en

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@nl

P1476

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

@en

P2093

Katerina N Apiranthiti

http://www.w3.org/2001/XMLSchema#string

Kyriakos K Trigkidis

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials

Guidelines for the management of adult lower respiratory tract infections--full version

Absorption and disposition kinetics of amoxicillin in normal human subjects.

Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

P31

scholarly article

P356

10.1111/ECI.12845

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Konstantinos Z Vardakas

Matthew E. Falagas

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29027205

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer